SlideShare a Scribd company logo
1 of 3
Download to read offline
2016
Pharmacy
Program
Belgium
Our jointly sponsored
benchmarking reports
provide an ongoing industry
scorecard designed to help
retailers and manufacturers
measure, track, and
strengthen their performance
with key business partners
Advantage Report™
Advantage is pleased to offer a Pharmacy
Program for Belgium. The Belgium
pharmaceutical industry is characterized
by massive investments, long and rigorous
product development and great financial
risk. Only two of ten drugs will recoup the
money invested into their development
The pharma industry must deploy a
framework that is collaborative
hospitable, stable, predictable and
sustainable. Our Pharmacy Program can
play a pivotal role in helping you achieve
these goals.
1
• Pharmacy sales represent almost 70% of the
market with 30% accruing to hospitals
• Investment in jobs and R&D for the
pharmaceutical industry in Belgium
continued to increase despite declines in the
global and domestic economy
• Research indicates Collaboration is a key
driver to the success of the Belgium
Pharmaceutical Industry with all stakeholders
work together in pursuit of greater efficiency
• The increase demand for generic drugs has
placed deflationary pressure on overall prices
• The structure of the pharmacy channel and
number of decision makers continues to
evolve with more and more pharmacies
belonging to a chain or buying group.
Advantage Report™
Pharmacy Program - Belgium
Why you need Advantage
Pharmacy Programs
• We measure collaboration through
our flagship service – Advantage
Report® and Advantage Report®
Mirror . It is a business tool used to
evaluate a company’s performance
relative to their competition and
peers, identifies strengths,
weaknesses and opportunities as
well as priorities for supplier
support.
• Advantage Report combines
extensive quantitative data with
qualitative feedback to provide
actionable insight.
• Feedback is obtained from multiple
functional areas
Pharmacies
2
Why you should participate
• Leading Fortune 500 Companies look
to Advantage to strengthen their
business relationships through
benchmarking
• Pharmacies and their suppliers are
rated and ranked in key performance
areas and practices
• Ability to Benchmark against “Best in
Class “ with a positive impact on
market share and profitable growth
• 3600 view of pharmacies and suppliers
relationships that lets you know
where you rank and key drivers of
performance
Pharmacy Market Trends Belgium
• TBA
Advantage Report TM
Advantage is present in 40 countries
3
Key Performance Areas
For Suppliers - Advantage Report™
Suppliers receive Advantage Report which
offers retailers the opportunity to
communicate their priorities and expectations
to their suppliers
For Pharmacies - Advantage
Report Mirror™ Pharmacies will receive
Advantage Report Mirror in which suppliers
evaluate their performance and allows
pharmacies to identify strengths and
opportunity areas for improvement.
For more information on how to
participate, please contact:
Bart Laumans
Country Manager Advantage Benelux
Tel + 31 (0) 416 383 901
GSM : + 31 (0) 6 5326 7120
The Advantage
Pharmacy Opportunity
OCT
2016
NOV
2016
DEC
2016
JAN
2017
FEB
2017
MAR
2017
AUG
2016
SEP
2016
Advantage Report
Advantage Report Mirror
In-Field ResultsDemo - Project Timeline:
Understanding My
Rank/Perception Versus
Competition (Overall;
Against 30+ Practices;
Against retailer Priorities)
Drive Systemic Change
Internally (What are the
key opportunities we
can/should address?)
Improving Business
Relationship and Business
Planning with Pharmacies
and Suppliers Overall
Performance
Relationship People
Advantage Report®
For Suppliers
Advantage Report®
Mirror
For Pharmacies
Customer
Marketing
Supply
Chain
Customer
Service
Consumer
Marketing
Category
Development

More Related Content

What's hot

Walgreens Community Management Project
Walgreens Community Management ProjectWalgreens Community Management Project
Walgreens Community Management Project
james pham 🧠
 

What's hot (20)

Supply Chain Efficiency – A Lever for Enhanced Competitiveness
Supply Chain Efficiency – A Lever for Enhanced CompetitivenessSupply Chain Efficiency – A Lever for Enhanced Competitiveness
Supply Chain Efficiency – A Lever for Enhanced Competitiveness
 
e-Pharmacies in INDIA
e-Pharmacies in INDIAe-Pharmacies in INDIA
e-Pharmacies in INDIA
 
Key Account Management - Time for India Pharma to Adopt KAM
Key Account Management - Time for India Pharma to Adopt KAMKey Account Management - Time for India Pharma to Adopt KAM
Key Account Management - Time for India Pharma to Adopt KAM
 
Pharmacy Delivery Service Business Plan
Pharmacy Delivery Service Business PlanPharmacy Delivery Service Business Plan
Pharmacy Delivery Service Business Plan
 
Tech emerge webinar2 planning
Tech emerge webinar2 planningTech emerge webinar2 planning
Tech emerge webinar2 planning
 
Final Ib Ranbaxy
Final Ib RanbaxyFinal Ib Ranbaxy
Final Ib Ranbaxy
 
Competition and Pharmaceuticals - Sabine Vogler - 2014 OECD Global Forum on C...
Competition and Pharmaceuticals - Sabine Vogler - 2014 OECD Global Forum on C...Competition and Pharmaceuticals - Sabine Vogler - 2014 OECD Global Forum on C...
Competition and Pharmaceuticals - Sabine Vogler - 2014 OECD Global Forum on C...
 
Competition and Pharmaceuticals - Pradeep Mehta - 2014 OECD Global Forum on C...
Competition and Pharmaceuticals - Pradeep Mehta - 2014 OECD Global Forum on C...Competition and Pharmaceuticals - Pradeep Mehta - 2014 OECD Global Forum on C...
Competition and Pharmaceuticals - Pradeep Mehta - 2014 OECD Global Forum on C...
 
Competition and Pharmaceuticals - Panos Kanavos - 2014 OECD Global Forum on ...
Competition and Pharmaceuticals - Panos Kanavos  - 2014 OECD Global Forum on ...Competition and Pharmaceuticals - Panos Kanavos  - 2014 OECD Global Forum on ...
Competition and Pharmaceuticals - Panos Kanavos - 2014 OECD Global Forum on ...
 
Sales and distribution of pharmaceutical industry
Sales and distribution of pharmaceutical industrySales and distribution of pharmaceutical industry
Sales and distribution of pharmaceutical industry
 
Competition and Pharmaceuticals - Farasat Bokhari - 2014 OECD Global Forum on...
Competition and Pharmaceuticals - Farasat Bokhari - 2014 OECD Global Forum on...Competition and Pharmaceuticals - Farasat Bokhari - 2014 OECD Global Forum on...
Competition and Pharmaceuticals - Farasat Bokhari - 2014 OECD Global Forum on...
 
Walgreens Community Management Project
Walgreens Community Management ProjectWalgreens Community Management Project
Walgreens Community Management Project
 
Smart medic
Smart medicSmart medic
Smart medic
 
2o OTC & Cosmetics Conference, Νίκος Κωστάρας
2o OTC & Cosmetics Conference, Νίκος Κωστάρας2o OTC & Cosmetics Conference, Νίκος Κωστάρας
2o OTC & Cosmetics Conference, Νίκος Κωστάρας
 
Competition and Pharmaceuticals - Adrian Majumdar - 2014 OECD Global Forum on...
Competition and Pharmaceuticals - Adrian Majumdar - 2014 OECD Global Forum on...Competition and Pharmaceuticals - Adrian Majumdar - 2014 OECD Global Forum on...
Competition and Pharmaceuticals - Adrian Majumdar - 2014 OECD Global Forum on...
 
Health 2.0 Quarterly Report (Q2 2016)
Health 2.0 Quarterly Report (Q2 2016) Health 2.0 Quarterly Report (Q2 2016)
Health 2.0 Quarterly Report (Q2 2016)
 
Top pharmacy billing guidelines
Top pharmacy billing guidelinesTop pharmacy billing guidelines
Top pharmacy billing guidelines
 
7 Things about Pharmacy Billing and Reimbursement
7 Things about Pharmacy Billing and Reimbursement7 Things about Pharmacy Billing and Reimbursement
7 Things about Pharmacy Billing and Reimbursement
 
Malaysia's Emerging Pharmacy Channel
Malaysia's Emerging Pharmacy ChannelMalaysia's Emerging Pharmacy Channel
Malaysia's Emerging Pharmacy Channel
 
Epharma Business Plan
Epharma Business PlanEpharma Business Plan
Epharma Business Plan
 

Similar to Pharmacy Performance & Benchmarking Advantage

Ensuring Profitable Patient Adherence Programs (mini)
Ensuring Profitable Patient Adherence Programs  (mini)Ensuring Profitable Patient Adherence Programs  (mini)
Ensuring Profitable Patient Adherence Programs (mini)
Eularis
 
Results of THoM Healthcare marketing survey 2009
Results of THoM Healthcare marketing survey 2009Results of THoM Healthcare marketing survey 2009
Results of THoM Healthcare marketing survey 2009
bdereus
 
Strategic_management_project.docx.pdf
Strategic_management_project.docx.pdfStrategic_management_project.docx.pdf
Strategic_management_project.docx.pdf
MaiGaber4
 

Similar to Pharmacy Performance & Benchmarking Advantage (20)

Bench datamonitor
Bench datamonitorBench datamonitor
Bench datamonitor
 
Apresentação Institucional Abril/2017
Apresentação Institucional Abril/2017Apresentação Institucional Abril/2017
Apresentação Institucional Abril/2017
 
Institutional Presentation Hypera Pharma
Institutional Presentation Hypera PharmaInstitutional Presentation Hypera Pharma
Institutional Presentation Hypera Pharma
 
Apresentação Institucional - Hypermarcas
Apresentação Institucional - HypermarcasApresentação Institucional - Hypermarcas
Apresentação Institucional - Hypermarcas
 
Pharma corporate reputation
Pharma corporate reputationPharma corporate reputation
Pharma corporate reputation
 
Ppt inst 21.03.18
Ppt inst 21.03.18Ppt inst 21.03.18
Ppt inst 21.03.18
 
QualityRx Brochure
QualityRx BrochureQualityRx Brochure
QualityRx Brochure
 
Apresentação Institucional Hypermarcas Agosto 2017
Apresentação Institucional Hypermarcas Agosto 2017Apresentação Institucional Hypermarcas Agosto 2017
Apresentação Institucional Hypermarcas Agosto 2017
 
Diplomat Pharmacy Inc - November 2016 Investors Presentation
Diplomat Pharmacy Inc - November 2016 Investors PresentationDiplomat Pharmacy Inc - November 2016 Investors Presentation
Diplomat Pharmacy Inc - November 2016 Investors Presentation
 
Ensuring Profitable Patient Adherence Programs (mini)
Ensuring Profitable Patient Adherence Programs  (mini)Ensuring Profitable Patient Adherence Programs  (mini)
Ensuring Profitable Patient Adherence Programs (mini)
 
Results of THoM Healthcare marketing survey 2009
Results of THoM Healthcare marketing survey 2009Results of THoM Healthcare marketing survey 2009
Results of THoM Healthcare marketing survey 2009
 
Apresentação Institucional - Hypermarcas
Apresentação Institucional - HypermarcasApresentação Institucional - Hypermarcas
Apresentação Institucional - Hypermarcas
 
2o OTC & Cosmetics Conference, Κωνσταντίνος Ουζούνης
2o OTC & Cosmetics Conference, Κωνσταντίνος Ουζούνης2o OTC & Cosmetics Conference, Κωνσταντίνος Ουζούνης
2o OTC & Cosmetics Conference, Κωνσταντίνος Ουζούνης
 
Pegging Brand Performance Measures to the Metrics that Really Matter
Pegging Brand Performance Measures to the Metrics that Really MatterPegging Brand Performance Measures to the Metrics that Really Matter
Pegging Brand Performance Measures to the Metrics that Really Matter
 
EVA pharma document
EVA pharma documentEVA pharma document
EVA pharma document
 
Dsp investor deck jp morgan january 2017 final2
Dsp investor deck jp morgan january 2017 final2Dsp investor deck jp morgan january 2017 final2
Dsp investor deck jp morgan january 2017 final2
 
Pitch deck- Bijana Healthcare Private Limited
Pitch deck- Bijana Healthcare Private LimitedPitch deck- Bijana Healthcare Private Limited
Pitch deck- Bijana Healthcare Private Limited
 
Strategic_management_project.docx.pdf
Strategic_management_project.docx.pdfStrategic_management_project.docx.pdf
Strategic_management_project.docx.pdf
 
Drive Product Access For Patients And Physicians - Successful Managed Care Pu...
Drive Product Access For Patients And Physicians - Successful Managed Care Pu...Drive Product Access For Patients And Physicians - Successful Managed Care Pu...
Drive Product Access For Patients And Physicians - Successful Managed Care Pu...
 
EY_PME_Mar16
EY_PME_Mar16EY_PME_Mar16
EY_PME_Mar16
 

Pharmacy Performance & Benchmarking Advantage

  • 1. 2016 Pharmacy Program Belgium Our jointly sponsored benchmarking reports provide an ongoing industry scorecard designed to help retailers and manufacturers measure, track, and strengthen their performance with key business partners Advantage Report™ Advantage is pleased to offer a Pharmacy Program for Belgium. The Belgium pharmaceutical industry is characterized by massive investments, long and rigorous product development and great financial risk. Only two of ten drugs will recoup the money invested into their development The pharma industry must deploy a framework that is collaborative hospitable, stable, predictable and sustainable. Our Pharmacy Program can play a pivotal role in helping you achieve these goals. 1
  • 2. • Pharmacy sales represent almost 70% of the market with 30% accruing to hospitals • Investment in jobs and R&D for the pharmaceutical industry in Belgium continued to increase despite declines in the global and domestic economy • Research indicates Collaboration is a key driver to the success of the Belgium Pharmaceutical Industry with all stakeholders work together in pursuit of greater efficiency • The increase demand for generic drugs has placed deflationary pressure on overall prices • The structure of the pharmacy channel and number of decision makers continues to evolve with more and more pharmacies belonging to a chain or buying group. Advantage Report™ Pharmacy Program - Belgium Why you need Advantage Pharmacy Programs • We measure collaboration through our flagship service – Advantage Report® and Advantage Report® Mirror . It is a business tool used to evaluate a company’s performance relative to their competition and peers, identifies strengths, weaknesses and opportunities as well as priorities for supplier support. • Advantage Report combines extensive quantitative data with qualitative feedback to provide actionable insight. • Feedback is obtained from multiple functional areas Pharmacies 2 Why you should participate • Leading Fortune 500 Companies look to Advantage to strengthen their business relationships through benchmarking • Pharmacies and their suppliers are rated and ranked in key performance areas and practices • Ability to Benchmark against “Best in Class “ with a positive impact on market share and profitable growth • 3600 view of pharmacies and suppliers relationships that lets you know where you rank and key drivers of performance Pharmacy Market Trends Belgium • TBA
  • 3. Advantage Report TM Advantage is present in 40 countries 3 Key Performance Areas For Suppliers - Advantage Report™ Suppliers receive Advantage Report which offers retailers the opportunity to communicate their priorities and expectations to their suppliers For Pharmacies - Advantage Report Mirror™ Pharmacies will receive Advantage Report Mirror in which suppliers evaluate their performance and allows pharmacies to identify strengths and opportunity areas for improvement. For more information on how to participate, please contact: Bart Laumans Country Manager Advantage Benelux Tel + 31 (0) 416 383 901 GSM : + 31 (0) 6 5326 7120 The Advantage Pharmacy Opportunity OCT 2016 NOV 2016 DEC 2016 JAN 2017 FEB 2017 MAR 2017 AUG 2016 SEP 2016 Advantage Report Advantage Report Mirror In-Field ResultsDemo - Project Timeline: Understanding My Rank/Perception Versus Competition (Overall; Against 30+ Practices; Against retailer Priorities) Drive Systemic Change Internally (What are the key opportunities we can/should address?) Improving Business Relationship and Business Planning with Pharmacies and Suppliers Overall Performance Relationship People Advantage Report® For Suppliers Advantage Report® Mirror For Pharmacies Customer Marketing Supply Chain Customer Service Consumer Marketing Category Development